АРИТМОГЕННАЯ КАРДИОМИОПАТИЯ/ДИСПЛАЗИЯ ПРАВОГО ЖЕЛУДОЧКА: КЛИНИЧЕСКИЕ И МОЛЕКУЛЯРНО-ГЕНЕТИЧЕСКИЕ ОСОБЕННОСТИ
Аннотация
Рассматриваются вопросы этиологии, патогенеза, диагностики и лечения аритмогенной кардиомиопатии/дисплазии правого желудочка, характер ее клинического течения, необходимость профилактики внезапной сердечной смерти.
Об авторах
М. А. Федяков
СПб ГБУЗ «Городская больница № 40»
Россия
Россия
О. Е. Велеславова
Северо-западный центр диагностики и лечения аритмий СПбГУ
Россия
Россия
О. С. Глотов
СПб ГБУЗ «Городская больница № 40»; Институт трансляционной биомедицины СПбГУ
Россия
Россия
С. В. Апалько
СПб ГБУЗ «Городская больница № 40»
Россия
Россия
А. М. Сарана
СПб ГБУЗ «Городская больница № 40»; СПбГУ
Россия
Россия
С. Г. Щербак
СПб ГБУЗ «Городская больница № 40»; СПбГУ
Россия
Россия
Список литературы
1. Велеславова О.Е, Гордеева М. В., Железняк И.С и др. Аритмогенная кардиомиопатия/дисплазия правого желудочка // Вестник Санкт-Петербургского Университета Серия 11 Медицина 2014 Том 1 с. 26-42.
2. М.В. Гордеева, Велеславова О.Е, Батурова М.А. и др. Внезапная ненасильственная смерть молодых людей (ретроспективный анализ) // Вестник аритмологии № 65, 2011, c. 25-32.
3. М.В. Гордеева, Л.Б. Митрофанова, А.В. Пахомов и др. Аритмогенная кардиомиопатия/дисплазия правого желудочка как причина внезапной сердечной смерти молодых людей // Вестник аритмологии № 69, 2012, c. 38-48.
4. Камиев Р.Т Романов А.Б. Елесин Д.А и др. Катетерная аблация желудочковых тахикардий при аритмоген-ной дисплазии правого желудочка после неэффективной эндокардиальной катетерной аблации. // Патология кровообращения и кардиохирургия. - 2012. - Т4, с. 49-53.
5. Митрофанова Л.Б., Бещук О.В., Татарский Р.Б., Лебедев Д. С. Аритмогенная кардиомиопатия правого желудочка и вирусная инфекция: возможные сочетания и роль в генезе желудочковых тахиаритмий // Вестник Аритмологии. 2009. № 58. с. 15-20.
6. Andreasen C., Nielsen J.B., Refsgaard L. et al. New population-based exome data are questioning the pathogenicity of previously cardiomyopathy-associated genetic variants // Eur J Hum Genet. 2013 Sep; 21 (9): 918-28.
7. Glotov A.S., Kazakov S.V., Zhukova E.A. et al. Targeted next-generation sequencing (NGS) of nine candidate genes with custom AmpliSeq in patients and a cardiomyopathy risk group // Clinica Chimica Acta. V. 446 (2015) P. 132-140.
8. Antoniades L., Tsatsopoulou A., Anastasakis A. et al. Arrhythmogenic right ventricular cardiomyopathy caused by deletions in plakophilin-2 and plakoglobin (Naxos disease) in families from Greece and Cyprus: genotype-phenotype relations, diagnostic features and prognosis // Eur Heart J. 2006 Sep; 27(18): 2208-16.
9. Asimaki A., Syrris P., Wichter T. et al. A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy // Am J Hum Genet, 2007, 81: 964-973.
10. Azaouagh et al, 2010. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a review and update // Clin Res Cardiol (2011) 100: 383-394.
11. Barahona-Dussault C., Benito B., Campuzano O. et al. Role of genetic testing in arrhythmogenic right ventricular cardiomyopathy/dysplasia // Clin Genet. 2010; 77: 37-48.
12. Basso C., Corrado D., Marcus F.I. et al. Arrhythmogenic right ventricular cardiomyopathy // Lancet 2009, 373: 12891300.
13. Bauce B., Basso C., Rampazzo A. et al. Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations // Eur Heart J. 2005; 26: 1666-75.
14. Beffagna G., Occhi G., Nava A. et al. Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1 // Cardiovasc Res. 2005, 65: 366-373.
15. Bhonsale A., Groeneweg J.A., James C.A. et al. Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers. Eur Heart J 2015, Epub ahead of print.
16. Bhuiyan Z.A., Jongbloed J.D.H., van der Smagt J. et al. Desmoglein-2 and desmocollin-2 mutations in Dutch ar-rhythmogenic right ventricular dysplasia/cardiomyopathy patients: results from a multicenter study // Circ Cardiovasc Genet. 2009; 2: 418-27.
17. Calabrese F., Basso C., Carturan E. et al. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: is there a role for viruses? // Cardiovasc Pathol 2006, 15: 11-17.
18. Calabrese F., Carturan E., Thiene G., Towbin J.A. Arrhythmogenic in right ventricular cardiomyopathy/dysplasia. Possible causative or contributing role of viruses // Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia F. I. Marcus, A.Nava, G.Thiene. Milano: Springer, 2007. P. 79-85.
19. Carvajal-Huerta L. Epidermolytic palmoplantar kera-toderma with woolly hair and dilated cardiomyopathy // J Am Acad Dermatol. 1998; 39: 418-21.
20. Charron P., Arad M., Arbustini E. Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases // Eur Heart J. 2010 Nov; 31(22): 2715-26.
21. Christensen A.H., Benn M., Bundgaard H. et al. Wide spectrum of desmosomal mutations in Danish patients with arrhythmogenic right ventricular cardiomyopathy // J Med Genet. 2010b; 47: 736-44.
22. Christensen A.H., Benn M., Tybjaerg-Hansen A. et al. Missense variants in plakophilin-2 in arrhythmogenic right ventricular cardiomyopathy patients-disease causing or innocent bystanders // Cardiology, 2010; 115: 148-54.
23. Corrado D., Basso C., Leoni L. et al. Three-dimensional electroanatomic voltage mapping and histological evaluation of myocardial substrate in right ventricular outflow tract tachycardia // J Am Coll Cardiol. 2008 Feb 19; 51(7): 731-9.
24. Corrado D., Basso C., Schiavon M., Thiene G. Screening for hypertrophic cardiomyopathy in young athletes // N Engl J Med. 1998; 339: 364-9.
25. Corrado D., Basso C., Thiene G. Departments of Cardiology and Pathology. Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis,and treatment an update // Heart. 2000. Vol. 83. P. 588-595.
26. Corrado D., Basso C., Thiene G. et al. Spectrum of clinico-pathologic manifestation of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study // J. Am. Coll. Cardiol. 1997. Vol. 30, N 6.P. 1512-1520.
27. Dalal D., Nasir K., Bomma C. et al. Arrhythmogenic right ventricular dysplasia: a United States experience // Circulation. 2005; 112: 3823-32.
28. Dalal D., Jain R., Tandri H. et al. Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy // JACC. - 2007. - Vol. 50. - P. 432-440.
29. Delmar M., McKenna W.J. The cardiac desmosome and arrhythmogenic cardiomyopathies: from gene to disease // Circ Res. 2010 Sep 17; 107(6): 700-14.
30. Elliott P., O’Mahony C., Syrris P. et al. Prevalence of desmosomal protein gene mutations in patients with dilated cardiomyopathy. // Circ Cardiovasc Genet. 2010; 3: 314-22.
31. Fidler L.M., Wilson G.J., Liu F. et al. Abnormal connexin43 in arrhythmogenic right ventricular cardiomyopathy caused by plakophilin-2 mutations // J Cell Mol Med. 2009 Oct; 13(10): 4219-28.
32. Fiorelli A.I., Coelho G.H., Oliveira J.L. et al. Heart transplantation in arrhythmogenic right ventricular dysplasia: case reports // Transplant Proc 2009, 41(3): 962-964.
33. Fontaine G., Fontaliran F., Frank R. Arrhythmogenic right ventricular cardiomyopathies: clinical forms and main differential diagnoses // Circulation. 1998; 97: 1532-5.
34. Fressart V., Duthoit G., Donal E. et al. Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: spectrum of mutations and clinical impact in practice. Europace 2010, 12: 861-868.
35. Garcia-Gras E., Lombardi R., Giocondo M.J. et al. Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy // J Clin Invest. 2006; 116: 2012-21.
36. Garrod D., Chidgey M. Desmosome structure, composition and function // Biochimica et Biophysica Acta (BBA) - Biomembranes, Vol. 1778, Iss. 3, 2008, P. 572-587.
37. Gerull B., Heuser A., Wichter T. et al. Mutations in the desmosomal protein plakophilin-2 are common in ar-rhythmogenic right ventricular cardiomyopathy. Nat Genet 2004, 36: 1162-1164.
38. Girolami F., Iascone M., Tomberli B. et al. Novel Alpha-Actinin 2 Variant Associated with Familial Hypertrophic Cardiomyopathy and Juvenile Atrial Arrhythmias: A Massively Parallel Sequencing Study // Circ Cardiovasc Genet 2014, 7: 741-50.
39. Groeneweg J.A., Bhonsale A., James C.A. Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members // Circ Cardiovasc Genet. 2015 Jun; 8(3): 437-46.
40. Hamid M.S., Norman M., Quraishi A. et al. Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria // J Am Coll Cardiol 2002; 40: 1445-1450.
41. Heidbuchel H., Prior D.L., La Gerche A. Ventricular arrhythmias associated with long-term endurance sports: what is the evidence? // Br J Sports Med. 2012 Nov; 46 Suppl 1: i44-50.
42. Huber O.: Structure and function of desmosomal proteins and their role in development and disease // Cell Mol Life Sci 2003; 60: 1872- 1890.
43. Hulot J.S., Jouven X., Empana J.P. Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy // Circulation. 2004; 110: 1879-84.
44. Jacob K.A.1, Noorman M., Cox M.G. et al. Geographical distribution of plakophilin-2 mutation prevalence in patients with arrhythmogenic cardiomyopathy // Neth Heart J. 2012 May; 20(5): 234-9.
45. Kaplan S.R., Gard J.J., Protonotarios N. et al. Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease) // Heart Rhythm. 2004 May; 1(1): 3-11.
46. Kapplinger J.D., Landstrom A.P., Salisbury B.A. et al. Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background noise JACC. 2011; 57: 2317-27.
47. Kirchhof P., Fabritz L., Zwiener M. et al. Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice // Circulation. 2006; 114: 1799-1806.
48. La Gerche A., Robberecht C., Kuiperi C. et al. Lower than expected desmosomal gene mutation prevalence in endurance athletes with complex ventricular arrhythmias of right ventricular origin // Heart. 2010; 96: 1268-74.
49. Lacroix D., Lions C., Klug D., Prat A. Arrhythmogenic right ventricular dysplasia: catheter ablation, MRI, and heart transplantation // J Cardiovasc Electrophysiol 2005, 16: 235-236.
50. Lahtinen A.M., Lehtonen E., Marjamaa A., et al. Population-prevalent desmosomal mutations predisposing to arrhythmogenic right ventricular cardiomyopathy // Hear Rhythm. 2011; 8: 1214-21.
51. Lazzarini E., Jongbloed J.D.H., Pilichou K. et al. The ARVD/C Genetic Variants Database: 2014 Update // Hum Mutat. 2015 Apr; 36(4): 403-10.
52. Marcus F.I., McKenna W.J., Sherrill D. et al. Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/ Dysplasia. Proposed Modification of the Task Force Criteria. // Circulation. 2010. Vol. 121.P 1533-1541.
53. Marcus F.I., Zareba W., Calkins H. Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: Results from the North American Multidisciplinary Study // Heart Rhythm. 2009. Vol. 6. P. 984-992.
54. Marcus F.I., Fontaine G.H., Guiraudon G. et al. Right ventricular dysplasia: a report of 24 adult cases Circulation. 1982; 65: 384-98.
55. Marcus F.I., McKenna W.J., Sherrill D. et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria // Circulation. 2010; 121: 1533-41.
56. McKoy G., Protonotarios N., Crosby A et al. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease) // Lancet. 2000; 355: 2119-24.
57. Merner N.D., Hodgkinson K.A., Haywood A.F. et al. Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a mis-sense mutation in the TMEM43 gene // Am J Hum Genet 2008, 82: 809-821.
58. Nava A., Thiene G., Canciani B. et al. Familial occurrence of right ventricular dysplasia: a study involving nine families // J Am Coll Cardiol 1988, 12(5): 1222-1228.
59. Norgett E.E., Lucke T.W., Bowers B. et al. Early death from cardiomyopathy in a family with autosomal dominant striate palmoplantar keratoderma and woolly hair associated with a novel insertion mutation in desmoplakin // J Invest Dermatol 2006, 126: 1651-1654.
60. Norman M.W., McKenna W.J.: Arrhythmogenic right ventricular cardiomyopathy/dysplasia: perspectives on diseases // Z Kardiol 1999, 88: 550-554.
61. Otten E., Asimaki A., Maass A. et al. Desmin mutations as a cause of right ventricular heart failure affect the intercalated disks // Heart Rhythm. 2010; 7: 1058-1064.
62. Peters S., Trümmel M., Meyners W. Prevalence of right ventricular dysplasia-cardiomyopathy in a non-referral hospital // Int J Cardiol 2004; 97: 499 -501.
63. Pilichou K., Nava A., Basso C. et al. Mutations in desmoglein- gene are associated with arrhythmogenic right ventricular cardiomyopathy // Circulation 2006, 113: 1171 -1179.
64. Protonotarios N., Tsatsopoulou A., Anastasakis A. et al. Genotype-phenotype assessment in autosomal recessive arrhythmogenic right ventricular cardiomyopathy (Naxos disease) caused by a deletion in plakoglobin // J Am Coll Cardiol. 2001; 38: 1477-84.
65. Quarta G., Syrris P., Ashworth M. et al. Mutations in the Lamin A/C gene mimic arrhythmogenic right ventricular cardiomyopathy // Eur Heart J 2012, 33: 1128-1136.
66. Rampazzo A., Nava A., Danieli G.A. et al. The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23-q24 // Hum Mol Genet 1994; 3: 959 -962.
67. Rampazzo A., Nava A., Malacrida S. et al. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy // Am J Hum Genet. 2002; 71: 1200-6.
68. Rigato I., Bauce B., Rampazzo A. et al. Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy // Circ Cardiovasc Genet 2013, 6: 533-542.
69. Schaefer E., Helms P., Marcellin L. et al. Next-genera-tion sequencing (NGS) as a fast molecular diagnosis tool for left ventricular noncompaction in an infant with compound mutations in the MYBPC3 gene // Eur J Med Genet 2014, 57: 129-32.
70. Sen-Chowdhry S., Syrris P., McKenna W.J. Desmopla-kin disease in arrhythmogenic right ventricular cardiomyopathy: early genotype-phenotype studies // Eur Heart J 2005, 26: 1582-1584.
71. Sen-Chowdhry S., Syrris P., Prasad S.K. et al. Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity // J Am Coll Cardiol 2008, 52: 2175-2187.
72. Sen-Chowdhry S., Syrris P., Ward D. et al. Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression // Circulation. 2007; 115: 1710-20.
73. Syrris P., Ward D., Asimaki A. et al. Clinical expression of plakophilin-2 mutations in familial arrhythmogenic right ventricular cardiomyopathy // Circulation 2006, 113: 356 -364.
74. Syrris P., Ward D., Evans A. et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2 // Am J Genet 2006, 79: 978-984.
75. Taylor M., Graw S., Sinagra G. et al. Genetic variation in titin in arrhythmogenic right ventricular cardiomyopathy-overlap syndromes // Circulation 2011, 124: 876-885.
76. Te Rijdt W.P., Jongbloed J.D., de Boer R.A. et al. Clinical utility gene card for: arrhythmogenic right ventricular cardiomyopathy (ARVC) // Eur J Hum Genet. 2014 Feb; 22(2)
77. Thiene G., Basso C. Arrhythmogenic right ventricular cardiomyopathy: An update // Cardiovasc Pathol 2001, 10: 109-117.
78. Thiene G., Corrado D., Basso C. Arrhythmogenic right ventricular cardiomyopathy/dysplasia // Orphanet J Rare Dis. 2007; 2: 45.
79. Thiene G., Corrado D., Nava A. et al. Right ventricular cardiomyopathy: is there evidence of an inflammatory aetiology? // Eur Heart J 1991, 12: 22-25.
80. Thiene G., Nava A., Corrado D. et al. Right ventricular cardiomyopathy and sudden death in young people // N Engl J Med. 1988; 318: 129-33.
81. Tiso N., Stephan D.A., Nava A. et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2) // Hum Mol Genet 2001, 10: 189-194.
82. Uhl H.S. A previously undescribed congenital malformation of the heart: almost total absence of the myocardium of the right ventricle // Bull Johns Hopkins Hosp 1952, 91: 197-209.
83. Van der Zwaag P.A., Cox M.G.P.J., Van der Werf C., et al. Recurrent and founder mutations in the Netherlands // Neth Heart J. 2010; 18: 583-91.
84. Van der Zwaag P.A., van Rijsingen I.A., Asimaki A. et al. Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy // Eur J Heart Fail 2012, 14: 1199-1207.
85. Van Hengel J., Calore M., Bauce B. et al. Mutations in the area composita protein aT-catenin are associated with arrhythmogenic right ventricular cardiomyopathy // Eur Heart J 2013, 34: 201-210.
86. Van Tintelen J.P., Hofstra R.M., Wiesfeld A.C. et al. Molecular genetics of arrhythmogenic right ventricular cardiomyopathy: emerging horizon? // Curr Opin Cardiol 2007, 22: 185-192.
87. Vreeker A., van Stuijvenberg L., Hund T.J. et al. Assembly of the cardiac intercalated disk during pre- and postnatal development of the human heart // PLoS One. 2014 Apr 14; 9(4): e94722.
88. Watkins D.A., Hendricks N., Shaboodien G. et al. ARVC Registry of the Cardiac Arrhythmia Society of Southern Africa (CASSA). Clinical features, survival experience, and profile of plakophylin-2 gene mutations in participants of the arrhythmogenic right ventricular cardiomyopathy registry of South Africa // Hear Rhythm. 2009; 6(11 Suppl): S10-7.
89. Wichter T., Borggrefe M., Haverkamp W. et al. Efficacy of antiarrhythmic drugs in patients with arrythmogenic right ventricular disease. Results in patients with inducible and non-inducible ventricular tachycardia // Circulation.-1992.-Vol.86.-P.29-37.
90. Xu T., Yang Z., Vatta M. et al. Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy // J Am Coll Cardiol 2010, 55: 587-597.
Рецензия
Для цитирования:
Федяков М.А., Велеславова О.Е., Глотов О.С., Апалько С.В., Сарана А.М., Щербак С.Г. АРИТМОГЕННАЯ КАРДИОМИОПАТИЯ/ДИСПЛАЗИЯ ПРАВОГО ЖЕЛУДОЧКА: КЛИНИЧЕСКИЕ И МОЛЕКУЛЯРНО-ГЕНЕТИЧЕСКИЕ ОСОБЕННОСТИ. Вестник аритмологии. 2015;(81):33-41.
For citation:
Fedyakov M.A., Veleslavova O.E., Glotov O.S., Apalko S.V., Sarana A.M., Shcherbak S.G. ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY/DYSPLASIA: CLINICAL AND MOLECULAR GENETIC PECULIAR FEATURES. Journal of Arrhythmology. 2015;(81):33-41. (In Russ.)
Просмотров:
156
Послать статью по эл. почте 